首页> 外文OA文献 >Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study

【2h】

Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study

机译：吉非替尼整合方案与单纯化疗对重度表皮生长因子受体突变的肺腺癌患者的病例对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zhao Nan-Jie; Sun Zhao; Wang Yuzhou; Ning Xiaohong; Jia Ning; Meng Changting; Wang Yingyi;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study [J] . Nan-Jie Zhao, Zhao Sun, Yuzhou Wang, Translational Oncology . 2014,第4期

机译：吉非替尼整合方案 vs 对经重度治疗的表皮生长因子受体突变的肺腺癌患者的单独化疗：病例对照研究
2. Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma [J] . Bylicki Olivier, Guisier Florian, Monnet Isabelle, Medicine. . 2020,第3期

机译：预灌注患者的表皮生长因子受体 - 突变或促进淋巴瘤激酶 - 漂移肺腺癌患者预处理患者的疗效和安全性和其配体抑制剂的疗效和安全性
3. Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study. [J] . Asami K, Koizumi T, Hirai K, Clinical lung cancer . 2011,第6期

机译：吉非替尼作为老年表皮生长因子受体突变的晚期肺腺癌患者的一线治疗：长野县肺癌研究小组的一项研究结果。
4. Metabolomics approach for mice serum associated with epidermal growth factor receptor and BaP-induced mouse lung tumorigenesis using liquid chromatography-mass spectrometry [C] . Pinpin Lin, Chao-Yu Chen, Jhih-Sheng Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：使用液相色谱 - 质谱法与表皮生长因子受体相关的小鼠血清的代谢组种方法，液相色谱 - 质谱法
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study [O] . Nan-Jie Zhao, Zhao Sun, Yuzhou Wang, 2014

机译：吉非替尼整合方案与单纯化疗对重度表皮生长因子受体突变的肺腺癌患者的病例对照研究
7. Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study [O] . Nan-Jie Zhao, Zhao Sun, Yuzhou Wang, 2014

机译：吉非替尼整合方案与化疗相比，重度预处理的表皮生长因子受体突变肺腺癌患者：病例对照研究

Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study

著录项

引文网络

相似文献

相关主题

期刊订阅